These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 8852401

  • 1. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.
    Ragnhammar P, Blomgren H.
    Med Oncol; 1995 Sep; 12(3):187-201. PubMed ID: 8852401
    [No Abstract] [Full Text] [Related]

  • 2. The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
    Köhne CH, Wilke H, Schöffski P, Schmoll HJ.
    J Infus Chemother; 1996 Sep; 6(4):206-10. PubMed ID: 9229317
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trials referral resource. Treatment of advanced colorectal cancer.
    Cheson BD.
    Oncology (Williston Park); 1991 Apr; 5(4):61-2, 65-6, 68 passim. PubMed ID: 1831041
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials.
    Köhne-Wömpner CH, Schmoll HJ, Harstrick A, Rustum YM.
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):105-25. PubMed ID: 1373004
    [Abstract] [Full Text] [Related]

  • 5. Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity.
    Kemeny NE, Schneider A, Martin DS.
    Cancer Invest; 1990 Apr; 8(2):263-4. PubMed ID: 2400946
    [No Abstract] [Full Text] [Related]

  • 6. Biochemical modulation of 5-fluorouracil by PALA.
    O'Dwyer PJ.
    Cancer Invest; 1990 Apr; 8(2):261-2. PubMed ID: 2400945
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chemotherapy of advanced cancer of the colon and rectum.
    Bruckner HW, Motwani BT.
    Semin Oncol; 1991 Oct; 18(5):443-61. PubMed ID: 1925632
    [No Abstract] [Full Text] [Related]

  • 11. Biochemical modulation: a modality that has come of therapeutic age.
    Allegra CJ.
    J Clin Oncol; 1991 Oct; 9(10):1723-6. PubMed ID: 1919622
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacetyl-L-aspartic acid, and interferon alfa-2a in advanced colorectal cancer.
    Royce ME, McGarry W, Bready B, Dakhil SR, Belt RJ, Goodwin JW, Gray R, Hoff PM, Winn R, Pazdur R.
    J Clin Oncol; 1999 Oct; 17(10):3276-82. PubMed ID: 10506630
    [Abstract] [Full Text] [Related]

  • 17. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
    Guglielmi A, Aschele C, Grossi F, Tixi L, Sobrero A.
    Cytotechnology; 1996 Oct; 19(3):215-9. PubMed ID: 8862009
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.